Clinical Trial Update: RT-310 Dose Escalation BPH Study [Phase 1]

View source ↗

Summary

RT-310 is in a Phase 1 dose-escalation study for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms. The trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• RT-310

Snippet

Sponsor: Resurge Therapeutics Inc. | Conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms | Phase 1 | Status: ACTIVE_NOT_RECRUITING